Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Normann

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Brain Research|March 22, 2005
Selective modulation of Ca(2+) influx pathways by 5-HT regulates synaptic long-term plasticity in the hippocampusClaus Normann, Kristin Clark
Science (New York, N.Y.)|December 19, 2024
FDA should consider drug-therapy regimensEero Castrén, Claus Normann
European Archives of Psychiatry and Clinical Neuroscience|December 5, 2008
Neuroenhancement: status quo and perspectivesClaus Normann, Mathias Berger
The European Journal of Neuroscience|August 16, 2008
Induction mechanisms and modulation of bidirectional burst stimulation-induced synaptic plasticity in the hippocampusKristin Clark, Claus Normann
Der Nervenarzt|November 4, 2021
[Ketamine and other N-methyl-D-aspartate receptor modulators in treatment of depression]Stefan Vestring, Katharina Domschke, Claus Normann
BMC Psychiatry|April 7, 2016
The effect of oxytocin on attention to angry and happy faces in chronic depressionGregor Domes, Claus Normann, Markus Heinrichs
Journal of Clinical Psychopharmacology|January 19, 2002
Increased plasma concentration of maprotiline by coadministration of risperidoneClaus Normann, Klaus Lieb, Jörg Walden
European Archives of Psychiatry and Clinical Neuroscience|August 31, 2012
Neuroenhancement strategies for psychiatric disorders: rationale, status quo and perspectivesClaus Normann, Christoph Nissen, Lukas Frase
Journal of Visualized Experiments : Jove|October 11, 2021
Animal Models of Depression - Chronic Despair Model (CDM)Stefan Vestring, Tsvetan Serchov, Claus Normann
BMC Health Services Research|February 1, 2018
Hospital costs associated with psychiatric comorbidities: a retrospective studyJan Wolff, Thomas Heister, Claus Normann, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Brain Research|March 22, 2005
Selective modulation of Ca(2+) influx pathways by 5-HT regulates synaptic long-term plasticity in the hippocampusClaus Normann, Kristin Clark
Science (New York, N.Y.)|December 19, 2024
FDA should consider drug-therapy regimensEero Castrén, Claus Normann
European Archives of Psychiatry and Clinical Neuroscience|December 5, 2008
Neuroenhancement: status quo and perspectivesClaus Normann, Mathias Berger
The European Journal of Neuroscience|August 16, 2008
Induction mechanisms and modulation of bidirectional burst stimulation-induced synaptic plasticity in the hippocampusKristin Clark, Claus Normann
Der Nervenarzt|November 4, 2021
[Ketamine and other N-methyl-D-aspartate receptor modulators in treatment of depression]Stefan Vestring, Katharina Domschke, Claus Normann
BMC Psychiatry|April 7, 2016
The effect of oxytocin on attention to angry and happy faces in chronic depressionGregor Domes, Claus Normann, Markus Heinrichs
Journal of Clinical Psychopharmacology|January 19, 2002
Increased plasma concentration of maprotiline by coadministration of risperidoneClaus Normann, Klaus Lieb, Jörg Walden
European Archives of Psychiatry and Clinical Neuroscience|August 31, 2012
Neuroenhancement strategies for psychiatric disorders: rationale, status quo and perspectivesClaus Normann, Christoph Nissen, Lukas Frase
Journal of Visualized Experiments : Jove|October 11, 2021
Animal Models of Depression - Chronic Despair Model (CDM)Stefan Vestring, Tsvetan Serchov, Claus Normann
BMC Health Services Research|February 1, 2018
Hospital costs associated with psychiatric comorbidities: a retrospective studyJan Wolff, Thomas Heister, Claus Normann, et al.
Pageof 10